StocksFundsScreenerSectorsWatchlists
CLX

CLX - Clorox Co-The Stock Price, Fair Value and News

141.88USD-2.92 (-2.02%)Market Closed

Market Summary

CLX
USD141.88-2.92
Market Closed
-2.02%

CLX Stock Price

View Fullscreen

CLX RSI Chart

CLX Valuation

Market Cap

17.6B

Price/Earnings (Trailing)

220.1

Price/Sales (Trailing)

2.41

EV/EBITDA

40.35

Price/Free Cashflow

24.19

CLX Price/Sales (Trailing)

CLX Profitability

EBT Margin

2.15%

Return on Equity

150.94%

Return on Assets

1.35%

Free Cashflow Yield

4.13%

CLX Fundamentals

CLX Revenue

Revenue (TTM)

7.3B

Rev. Growth (Yr)

16.03%

Rev. Growth (Qtr)

43.58%

CLX Earnings

Earnings (TTM)

80.0M

Earnings Growth (Yr)

-6.06%

Earnings Growth (Qtr)

322.73%

Breaking Down CLX Revenue

Last 7 days

-2.8%

Last 30 days

-9.4%

Last 90 days

-1.0%

Trailing 12 Months

-10.7%

How does CLX drawdown profile look like?

CLX Financial Health

Current Ratio

0.89

Debt/Equity

46.77

Debt/Cashflow

0.38

CLX Investor Care

Dividend Yield

3.12%

Dividend/Share (TTM)

4.72

Shares Dilution (1Y)

0.47%

Diluted EPS (TTM)

0.64

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
YearQ1Q2Q3Q4
20237.2B7.4B7.0B7.3B
20227.1B7.1B7.0B7.1B
20217.5B7.3B7.2B7.1B
20206.4B6.7B7.1B7.5B
20196.3B6.2B6.2B6.1B
20186.1B6.1B6.2B6.2B
20175.9B6.0B6.0B6.0B
20165.7B5.8B5.8B5.9B
20155.6B5.7B5.7B5.7B
20145.5B5.5B5.5B5.6B
20135.5B5.5B5.5B5.5B
20125.4B5.4B5.4B5.5B
20115.2B5.2B5.3B5.3B
20105.3B5.2B5.2B5.2B
20095.4B5.5B5.4B5.4B
200805.3B5.3B5.4B
GRUFITY'S FAIR VALUE MODEL

Stocks Marked 'Very Cheap' by Grufity's Fair Value Model Have Outperformed S&P 500 Index

Grufity's Fair Value model takes all the S&P 500 stocks and divides them into separate buckets based on their attractiveness. The 'Very Cheap' bucket of S&P 500 has greatly outperformed S&P 500 Index. Conversely, S&P500 stocks considered 'Very Expensive' by the model underperformed the S&P500 index in the past three years. Grufity Fair Value is available for 2300+ stocks, including 90% of S&P 500 stocks. Grufity's Fair Value Model separates high-return stocks from low-return stocks.

PurpleZone


Returns of $10,000 invested in:

Very Cheap Stocks: $17,289
S&P 500 Index: $12,922
Very Expensive Stocks: $11,022


Grufity's Fair Value model does a great job in separating High Performing Stocks from Low Performing ones in the S&P 500 list.

S&P 500 Index
Very Expensive Stocks
Very Cheap Stocks
Try For Just $1.99

Tracking the Latest Insider Buys and Sells of Clorox Co-The

Filter Transactions
Datesorted ascendingNameBuy/Sell$ ValueAvg. Price# SharesTitle
Mar 28, 2024
williams christopher j
acquired
32,459
153
212
-
Mar 28, 2024
parker paul gray
acquired
13,014
153
85.00
-
Mar 28, 2024
banse amy
acquired
26,181
153
171
-
Mar 14, 2024
hyder chris t
sold (taxes)
-6,369
151
-42.00
group president - health & hyg
Mar 14, 2024
grier stacey
sold (taxes)
-6,369
151
-42.00
evp - executive chief of staff
Dec 29, 2023
parker paul gray
acquired
13,118
142
92.00
-
Dec 14, 2023
hilt angela c
sold (taxes)
-8,672
142
-61.00
evp - chief legal officer
Dec 11, 2023
reynolds eric h
sold (taxes)
-17,221
140
-123
evp - chief operating officer
Dec 11, 2023
jacobsen kevin b
sold (taxes)
-11,900
140
-85.00
evp - chief financial officer
Dec 11, 2023
grier stacey
sold (taxes)
-17,781
140
-127
evp - chief growth & str ofc

1–10 of 50

Which funds bought or sold CLX recently?

View All Details
Datesorted ascendingFund NameType% Chg$ Change$ Held% Portfolio
Apr 11, 2024
Security Financial Services, INC.
new
-
234,105
234,105
0.05%
Apr 11, 2024
Independent Wealth Network Inc.
sold off
-100
-511,930
-
-%
Apr 11, 2024
DHJJ Financial Advisors, Ltd.
unchanged
-
316
4,594
-%
Apr 11, 2024
Gulf International Bank (UK) Ltd
unchanged
-
108,000
1,572,000
0.04%
Apr 11, 2024
RFG Advisory, LLC
added
0.18
30,604
434,403
0.01%
Apr 11, 2024
Radnor Capital Management, LLC
unchanged
-
35,000
507,000
0.09%
Apr 11, 2024
CITY HOLDING CO
reduced
-15.51
-27,959
273,585
0.04%
Apr 11, 2024
Fortitude Family Office, LLC
reduced
-84.47
-24,474
4,900
-%
Apr 11, 2024
West Financial Advisors, LLC
unchanged
-
662
9,646
-%
Apr 11, 2024
Hummer Financial Advisory Services Inc
unchanged
-
23,922
348,172
0.29%

1–10 of 50

Are Funds Buying or Selling CLX?

Are funds buying CLX calls or puts?
Calls
Puts
No. of funds holding Calls - Puts
Net Call Options
No. of funds that own CLX
No. of Funds

Unveiling Clorox Co-The's Major ShareHolders

Date FiledName of FilerPercent of ClassNo. of SharesForm Type
Feb 13, 2024
vanguard group inc
12.28%
15,228,898
SC 13G/A
Jan 25, 2024
blackrock inc.
8.2%
10,119,551
SC 13G/A
Jan 25, 2024
state street corp
6.78%
8,410,519
SC 13G/A
Feb 09, 2023
vanguard group inc
12.28%
15,151,580
SC 13G/A
Feb 06, 2023
state street corp
7.17%
8,844,196
SC 13G/A
Jan 31, 2023
blackrock inc.
7.5%
9,267,422
SC 13G/A
Feb 14, 2022
state street corp
6.71%
8,240,920
SC 13G/A
Feb 09, 2022
vanguard group inc
11.80%
14,500,034
SC 13G/A
Feb 01, 2022
blackrock inc.
8.8%
10,774,842
SC 13G/A
Feb 12, 2021
state street corp
5.89%
7,426,780
SC 13G

Recent SEC filings of Clorox Co-The

View All Filings
Date Filed Form Type Document
Apr 02, 2024
4
Insider Trading
Apr 02, 2024
4
Insider Trading
Apr 02, 2024
4
Insider Trading
Apr 02, 2024
4
Insider Trading
Apr 02, 2024
4
Insider Trading
Apr 02, 2024
4
Insider Trading
Apr 02, 2024
4
Insider Trading
Apr 02, 2024
4
Insider Trading
Mar 25, 2024
4
Insider Trading
Mar 21, 2024
8-K
Current Report

Peers (Alternatives to Clorox Co-The)

NameMkt Capsorted ascendingRevenuePrice %, 1MReturns, 1YP/EP/SRev 1-YrInc 1-Yr
LARGE-CAP
365.5B
83.9B
-4.29% 2.35%
24.75
4.35
4.55% 3.44%
70.6B
19.5B
-3.80% 12.14%
30.71
3.63
8.29% 28.85%
49.8B
15.2B
-12.13% -44.82%
103.04
3.28
-7.33% -68.01%
24.6B
5.9B
-4.11% 12.75%
32.61
4.2
9.16% 82.56%
17.6B
7.3B
-9.40% -10.74%
220.1
2.41
3.47% -81.61%
9.4B
6.0B
-16.57% -13.63%
29.08
1.57
14.07% 132.95%
9.0B
890.1M
-21.12% 86.88%
69.86
10.15
79.24% 176.22%
MID-CAP
4.0B
1.3B
-7.68% -13.61%
26.51
3.07
21.26% 26.23%
3.0B
8.1B
-8.94% -41.27%
-7.61
0.36
-14.02% -296.95%
2.9B
872.0M
-7.61% 39.00%
-124.21
3.35
65.49% 64.15%
2.4B
2.0B
-16.60% 12.48%
14.62
1.18
-7.82% 10.32%
SMALL-CAP
1.8B
2.3B
-4.81% -16.20%
16.69
0.79
4.31% 6.67%
154.6M
191.5M
8.69% 61.38%
8.69
0.81
-1.27% 486.29%
56.1M
259.3M
-9.66% 253.33%
-1.3
0.22
-19.36% 50.71%
35.1M
10.9M
-2.92% -15.60%
13.62
3.23
-14.28% 0.46%

Clorox Co-The News

Latest updates
Defense World12 Apr 202411:11 am
Markets Insider09 Apr 202405:12 pm
Yahoo Finance25 Mar 202407:00 am
InvestorsObserver14 Mar 202406:20 pm
Sure Dividend28 Feb 202408:00 am

Clorox Co-The Earnings Report: Key Takeaways & Analysis

Income Statement (Last 12 Months)
(In Millions)
Income Statement (Quarterly)
(In Millions)
(*) denotes actual numbers (not divided by Millions)
Description(%) Q/Q2023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q12018Q4
Revenue43.6%1,9901,3862,0191,9151,7151,7401,8011,8091,6911,8061,8021,7811,8421,9161,9831,7831,4491,5061,6271,5511,473
Gross Profit62.8%866532862800620626668649558670668774837920929832639663734673643
  S&GA Expenses16.7%322276329311282261244233241236260237269238279269210211217216211
  R&D Expenses10.3%32.0029.0038.0035.0033.0032.0034.0031.0034.0033.0045.0032.0040.0032.0042.0039.0034.0030.0038.0034.0032.00
EBITDA Margin-2.2%0.07*0.07*0.08*0.07*0.13*0.12*0.13*0.13*0.09*0.12*0.16*0.20*---------
Interest Expenses23.8%26.0021.0021.0024.0023.0022.0037.0021.0023.0025.0025.0025.0024.0025.0025.0024.0025.0025.0025.0024.0024.00
Income Taxes900.0%40.004.0056.00-36.0028.0029.0025.0048.0021.0042.001.00-71.0010985.0056.0050.0055.0051.0053.0042.00
Earnings Before Taxes369.0%13629.00237-24513011612920093.00185101-59.00332526395297235258292240224
EBT Margin0.1%0.02*0.02*0.03*0.02*0.08*0.08*0.09*0.08*0.05*0.08*0.12*0.16*---------
Net Income322.7%93.0022.00176-21199.0085.0010115069.0014297.00-61.00259415310241185203241187182
Net Income Margin-10.5%0.01*0.01*0.02*0.01*0.06*0.06*0.07*0.06*0.03*0.06*0.10*0.12*---------
Free Cashflow2625.0%101-4.00346285167132256166124-11.00284183---------
Balance Sheet
(In Millions)
Balance Sheet
(In Millions)
(*) denotes actual numbers (not divided by Millions)
Description(%) Q/Q2023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q12018Q4
Assets-1.4%5,9085,9915,9455,8186,0456,1536,1586,3226,1906,2746,3346,4416,8556,7776,2135,8505,4595,3975,1165,1625,073
  Current Assets-5.6%1,8041,9111,8281,7451,6221,7631,7251,8691,7411,8201,8291,9622,1032,1442,0201,7501,3031,2661,3051,3931,365
    Cash Equivalents-31.5%355518367242170280186243196214324497737867879505174157113180165
  Inventory-7.7%655710696735741755755803818785752688609534454457514504512556578
  Net PPE-0.2%1,3141,3171,3451,3151,3221,3221,3341,3121,2981,3011,3021,2511,2211,1761,1031,0471,0521,0341,0341,000992
  Goodwill0.5%1,2521,2461,2521,2501,5531,5471,5581,5721,5651,5661,5751,5741,8031,7932081,5681,5881,5851,5911,5891,586
Liabilities-2.9%5,6905,8605,5575,6465,5545,6575,4295,7465,6995,7275,7425,5035,4755,4665,3055,1554,9044,8474,5574,3814,331
  Current Liabilities-9.2%2,0222,2281,9171,9961,8782,0101,7842,6432,5962,6392,0561,8191,7381,5161,4181,7941,5131,4581,4401,2611,186
  Long Term Debt0.0%2,4792,4782,4772,4762,4762,4752,4741,8871,8861,8852,4842,4832,4832,7812,7802,2882,2882,2872,2872,2862,285
    LT Debt, Current--------600600899300300300--------
    LT Debt, Non Current0.0%2,4792,4782,4772,4762,4762,4752,4741,8871,8861,8852,4842,4832,4832,7812,7802,2882,2882,2872,2872,2862,285
Shareholder's Equity-59.5%53.001312203.004914967295764915475929381,3801,311908695555550559781742
  Retained Earnings-19.4%2412995834157828321,0489519491,0271,0361,0861,3023,8403,5673,3983,2923,2413,1503,0042,940
  Additional Paid-In Capital-0.1%1,2451,2461,2451,2321,2071,1931,2021,1951,1801,1661,1861,1901,1761,1461,1371,1111,0621,0431,0461,0331,014
Accumulated Depreciation0.9%2,7922,7682,7052,6722,6212,5752,5302,5102,4662,4222,3822,3512,3192,2702,2242,2032,1852,1562,1502,1252,109
Shares Outstanding0.1%124124124124123123123123123123126126---------
Minority Interest-1.8%165168168169170170173176178179181195196196-------
Float-----17,300---21,400---25,300---19,000---19,700
Cashflow (Last 12 Months)
(In Millions)
Cashflow (Quarterly)
(In Millions)
(*) denotes actual numbers (not divided by Millions)
Description(%) Q/Q2023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q12018Q4
Cashflow From Operations665.0%15320.0043034120917833522918141.00383264246383740308227271389154190
  Share Based Compensation23.1%16.0013.0013.0029.0021.0010.008.0019.0016.009.00-2.0017.0022.0013.0013.0018.0013.006.009.0016.0010.00
Cashflow From Investing-43.5%-33.00-23.00-81.00-55.00-42.00-45.00-62.00-55.00-56.00-56.00-111-83.00-107-151-107-47.00-56.00-42.00-70.00-49.00-41.00
Cashflow From Financing-267.1%-259155-227-211-280-35.00-326-128-143-92.00-447-420-277-247-26277.00-155-183-386-91.00-146
  Dividend Payments0%149149146146146145143143143142138140140140134133133133122123123
  Buy Backs----------25.0030030520010023.0030.0085.0011034672.0040.00

CLX Income Statement

2023-12-31
Condensed Consolidated Statements of Earnings and Comprehensive Income (Unaudited) - USD ($)
shares in Thousands, $ in Millions
3 Months Ended6 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2023
Dec. 31, 2022
Income Statement [Abstract]    
Net sales$ 1,990$ 1,715$ 3,376$ 3,455
Cost of products sold1,1241,0951,9782,209
Gross profit8666201,3981,246
Selling and administrative expenses322282598543
Advertising costs186156351317
Research and development costs32336165
Pension settlement charge17101710
Interest expense26234745
Other (income) expense, net(7)(4)530
Earnings before income taxes136130165246
Income tax expense40284457
Net earnings96102121189
Less: Net earnings attributable to noncontrolling interests3365
Net earnings attributable to Clorox$ 93$ 99$ 115$ 184
Net earnings per share attributable to Clorox    
Basic net earnings per share (in dollars per share)$ 0.75$ 0.81$ 0.93$ 1.49
Diluted net earnings per share (in dollars per share)$ 0.75$ 0.80$ 0.92$ 1.49
Weighted average shares outstanding (in thousands)    
Basic (in shares)124,176123,546124,075123,443
Diluted (in shares)124,620123,988124,635123,951
Comprehensive income$ 231$ 115$ 255$ 166
Less: Total comprehensive income attributable to noncontrolling interests3365
Total comprehensive income attributable to Clorox$ 228$ 112$ 249$ 161

CLX Balance Sheet

2023-12-31
Condensed Consolidated Balance Sheets - USD ($)
$ in Millions
Dec. 31, 2023
Jun. 30, 2023
Current assets  
Cash and cash equivalents$ 355$ 367
Receivables, net679688
Inventories, net655696
Prepaid expenses and other current assets11577
Total current assets1,8041,828
Property, plant and equipment, net of accumulated depreciation and amortization of $2,792 and $2,705, respectively1,3141,345
Operating lease right-of-use assets354346
Goodwill1,2521,252
Trademarks, net542543
Other intangible assets, net156169
Other assets486462
Total assets5,9085,945
Current liabilities  
Notes and loans payable24750
Current operating lease liabilities9287
Accounts payable and accrued liabilities1,6491,659
Income taxes payable34121
Total current liabilities2,0221,917
Long-term debt2,4792,477
Long-term operating lease liabilities311310
Other liabilities852825
Deferred income taxes2628
Total liabilities5,6905,557
Commitments and contingencies
Stockholders’ equity  
Preferred stock: $1.00 par value; 5,000,000 shares authorized; none issued or outstanding00
Common stock: $1.00 par value; 750,000,000 shares authorized; 130,741,461 shares issued as of December 31, 2023 and June 30, 2023; and 124,080,634 and 123,820,022 shares outstanding as of December 31, 2023 and June 30, 2023, respectively131131
Additional paid-in capital1,2451,245
Retained earnings241583
Treasury stock, at cost: 6,660,827 and 6,921,439 shares as of December 31, 2023 and June 30, 2023, respectively(1,205)(1,246)
Accumulated other comprehensive net (loss) income(359)(493)
Total Clorox stockholders’ equity53220
Noncontrolling interests165168
Total stockholders’ equity218388
Total liabilities and stockholders’ equity$ 5,908$ 5,945
CLX
The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States. The Household segment provides cat litter products under the Fresh Step and Scoop Away brands; bags and wraps under the Glad brand; and grilling products under the Kingsford brand in the United States. The Lifestyle segment offers dressings, dips, seasonings, and sauces primarily under the Hidden Valley brand; natural personal care products under the Burt's Bees brand; and water-filtration products under the Brita brand in the United States. The International segment provides laundry additives; home care products; water-filtration systems; digestive health products; grilling products; cat litter products; food products; bags and wraps; natural personal care products; and professional cleaning and disinfecting products internationally primarily under the Clorox, Ayudin, Clorinda, Poett, Pine-Sol, Glad, Brita, RenewLife, Ever Clean and Burt's Bees brands. It sells its products primarily through mass retailers; grocery outlets; warehouse clubs; dollar stores; home hardware centers; drug, pet, and military stores; third-party and owned e-commerce channels; and distributors, as well as a direct sales force The Clorox Company was founded in 1913 and is headquartered in Oakland, California.
 CEO
 WEBSITEthecloroxcompany.com
 INDUSTRYHousehold Products
 EMPLOYEES8700

Clorox Co-The Frequently Asked Questions


What is the ticker symbol for Clorox Co-The? What does CLX stand for in stocks?

CLX is the stock ticker symbol of Clorox Co-The. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Clorox Co-The (CLX)?

As of Fri Apr 12 2024, market cap of Clorox Co-The is 17.61 Billion. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of CLX stock?

You can check CLX's fair value in chart for subscribers.

What is the fair value of CLX stock?

You can check CLX's fair value in chart for subscribers. The fair value of Clorox Co-The is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of Clorox Co-The is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for CLX so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is Clorox Co-The a good stock to buy?

The fair value guage provides a quick view whether CLX is over valued or under valued. Whether Clorox Co-The is cheap or expensive depends on the assumptions which impact Clorox Co-The's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for CLX.

What is Clorox Co-The's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Fri Apr 12 2024, CLX's PE ratio (Price to Earnings) is 220.1 and Price to Sales (PS) ratio is 2.41. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. CLX PE ratio will change depending on the future growth rate expectations of investors.

What is 5 year return on Clorox Co-The's stock?

In the past 10 years, Clorox Co-The has provided 0.071 (multiply by 100 for percentage) rate of return.